Navigation Links
AACR, NCI and EORTC to host molecular targets and cancer therapeutics conference
Date:10/15/2009

What: The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics is the location to hear about late-breaking data on emerging cancer therapies. This year's conference brings together delegates from all over the world to discuss innovation in drug development, target selection and the impact of new discoveries in molecular and cell biology.

To help you plan your coverage of the conference, the program schedule is available online at www.aacr.org. Although the full abstracts will not be available until the conference, an electronic press kit containing the press releases and select highlighted abstracts will be available to subscribing reporters on Nov. 9, 2009, via Eurekalert and Newswise, and by request to the AACR Communications and Public Relations Department.

More than 1,000 abstracts will be presented for the first time at the conference, complementing an outstanding program of scientific and educational events. The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics attracts world leaders in cancer research and treatment, including clinical oncologists, industry leaders, basic scientists and translational researchers who are working to improve patient care with the ultimate goal of eradicating cancer.

When: Nov. 15-19, 2009

Where: Hynes Convention Center, Boston


'/>"/>

Contact: Natalie Poole
natalie.poole@aacr.org
267-646-0619
American Association for Cancer Research
Source:Eurekalert

Page: 1

Related biology news :

1. AACR, BCRF award inaugural grants in translational breast cancer research
2. Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics
3. New molecular regulators of hyperthyroidism and goiter
4. Carnegie Mellon scientists investigate initial molecular mechanism that triggers neuronal firing
5. UC health news: molecular pathway may predict chemotherapy effectiveness
6. New molecular clock from LLNL and CDC indicates smallpox evolved earlier than believed
7. Story ideas from Molecular & Cellular Proteomics
8. Lets talk -- new paradigms in the research of the biomolecular composition of water
9. Scientists unveil structure of molecular target of many drugs
10. Potential new therapeutic molecular target to fight cancer
11. NIH selects LIAI for major study on allergy molecular causes and possible treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ARMONK, N.Y. , Aug. 23, 2017  The general public,s help ... the human microbiome—the bacteria that live in and on the human body ... ... bacteria in the human microbiome, starting with the gut. The project's goal ... in disease. Photo credit: IBM ...
(Date:6/23/2017)... and ITHACA, N.Y. , ... and Cornell University, a leader in dairy research, today ... bioinformatics designed to help reduce the chances that the ... the onset of this dairy project, Cornell University has ... for Sequencing the Food Supply Chain, a food safety ...
(Date:5/16/2017)... , May 16, 2017   Bridge ... health organizations, and MD EMR Systems , ... development partner for GE, have established a partnership ... Portal product and the GE Centricity™ products, including ... EMR. These new integrations will ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Surgical Wound Market with the addition of its newest module, US Hemostats & ... market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
Breaking Biology Technology: